1. Home
  2. AMR vs IRON Comparison

AMR vs IRON Comparison

Compare AMR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Metallurgical Resources Inc.

AMR

Alpha Metallurgical Resources Inc.

HOLD

Current Price

$184.15

Market Cap

2.6B

Sector

Energy

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$61.22

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMR
IRON
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
AMR
IRON
Price
$184.15
$61.22
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$180.50
$101.67
AVG Volume (30 Days)
264.4K
923.6K
Earning Date
05-25-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,129,481,000.00
N/A
Revenue This Year
$13.69
N/A
Revenue Next Year
$14.62
$101.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$100.00
$30.82
52 Week High
$253.82
$99.50

Technical Indicators

Market Signals
Indicator
AMR
IRON
Relative Strength Index (RSI) 47.33 37.06
Support Level $148.87 $57.45
Resistance Level $187.87 $65.34
Average True Range (ATR) 9.42 5.98
MACD 0.25 0.02
Stochastic Oscillator 67.49 62.47

Price Performance

Historical Comparison
AMR
IRON

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: